Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Mandel

Showing results (131-140 of 221) with videos related to

Pageof 23
Sort By:
European Urology Oncology|May 29, 2025
Influence of Concomitant Androgen Deprivation Therapy and Its Duration for Salvage Radiation After Radical Prostatectomy: A Systematic Review and Network Meta-analysis According to Published DataQuynh Chi Le, Carolin Siech, Benedikt Hoeh, et al.
The Prostate|June 29, 2021
Increasing rates of NCCN high and very high-risk prostate cancer versus number of prostate biopsy coresMike Wenzel, Christoph Würnschimmel, Claudia C Ruvolo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2024
Real-World Comparison of Cabazitaxel Versus <sup>177</sup>Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate CancerMike Wenzel, Florestan Koll, Benedikt Hoeh, et al.
The Prostate|October 11, 2021
Survival rates with external beam radiation therapy in newly diagnosed elderly metastatic prostate cancer patientsMike Wenzel, Claudia Collà Ruvolo, Christoph Würnschimmel, et al.
The Prostate|March 5, 2021
The effect of lymph node dissection on cancer-specific survival in salvage radical prostatectomy patientsMike Wenzel, Christoph Würnschimmel, Luigi Nocera, et al.
Frontiers in Oncology|May 10, 2021
Impact of Time to Castration Resistance on Survival in Metastatic Hormone Sensitive Prostate Cancer Patients in the Era of Combination TherapiesMike Wenzel, Felix Preisser, Benedikt Hoeh, et al.
Clinical Genitourinary Cancer|February 2, 2021
Sex-Related Differences Include Stage, Histology, and Survival in Urethral Cancer PatientsMike Wenzel, Luigi Nocera, Claudia Collà Ruvolo, et al.
European Urology Focus|July 30, 2017
Does Cytoreductive Prostatectomy Really Have an Impact on Prognosis in Prostate Cancer Patients with Low-volume Bone Metastasis? Results from a Prospective Case-Control StudyThomas Steuber, Kasper D Berg, Martin A Røder, et al.
Frontiers in Surgery|October 26, 2020
Impact of "Time-From-Biopsy-to-Prostatectomy" on Adverse Oncological Results in Patients With Intermediate and High-Risk Prostate CancerTobias Engl, Philipp Mandel, Benedikt Hoeh, et al.
Virchows Archiv : an International Journal of Pathology|June 17, 2022
The significance of the extent of tissue embedding for the detection of incidental prostate carcinoma on transurethral prostate resection material: the more, the better?Jens Köllermann, Benedikt Hoeh, Daniel Ruppel, et al.
Pageof 23

Showing results (131-140 of 221) with videos related to

Sort By:
Pageof 23
European Urology Oncology|May 29, 2025
Influence of Concomitant Androgen Deprivation Therapy and Its Duration for Salvage Radiation After Radical Prostatectomy: A Systematic Review and Network Meta-analysis According to Published DataQuynh Chi Le, Carolin Siech, Benedikt Hoeh, et al.
The Prostate|June 29, 2021
Increasing rates of NCCN high and very high-risk prostate cancer versus number of prostate biopsy coresMike Wenzel, Christoph Würnschimmel, Claudia C Ruvolo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2024
Real-World Comparison of Cabazitaxel Versus <sup>177</sup>Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate CancerMike Wenzel, Florestan Koll, Benedikt Hoeh, et al.
The Prostate|October 11, 2021
Survival rates with external beam radiation therapy in newly diagnosed elderly metastatic prostate cancer patientsMike Wenzel, Claudia Collà Ruvolo, Christoph Würnschimmel, et al.
The Prostate|March 5, 2021
The effect of lymph node dissection on cancer-specific survival in salvage radical prostatectomy patientsMike Wenzel, Christoph Würnschimmel, Luigi Nocera, et al.
Frontiers in Oncology|May 10, 2021
Impact of Time to Castration Resistance on Survival in Metastatic Hormone Sensitive Prostate Cancer Patients in the Era of Combination TherapiesMike Wenzel, Felix Preisser, Benedikt Hoeh, et al.
Clinical Genitourinary Cancer|February 2, 2021
Sex-Related Differences Include Stage, Histology, and Survival in Urethral Cancer PatientsMike Wenzel, Luigi Nocera, Claudia Collà Ruvolo, et al.
European Urology Focus|July 30, 2017
Does Cytoreductive Prostatectomy Really Have an Impact on Prognosis in Prostate Cancer Patients with Low-volume Bone Metastasis? Results from a Prospective Case-Control StudyThomas Steuber, Kasper D Berg, Martin A Røder, et al.
Frontiers in Surgery|October 26, 2020
Impact of "Time-From-Biopsy-to-Prostatectomy" on Adverse Oncological Results in Patients With Intermediate and High-Risk Prostate CancerTobias Engl, Philipp Mandel, Benedikt Hoeh, et al.
Virchows Archiv : an International Journal of Pathology|June 17, 2022
The significance of the extent of tissue embedding for the detection of incidental prostate carcinoma on transurethral prostate resection material: the more, the better?Jens Köllermann, Benedikt Hoeh, Daniel Ruppel, et al.
Pageof 23